Role of rs7903146 polymorphism and adropin serum level in patients with diabetes mellitus; a case–control study from Isfahan, Iran

References

• Akcılar, R., et al., 2016. The effect of adropin on lipid and glucose metabolism in rats with hyperlipidemia. Iranian journal of basic medical sciences, 19(3), 245.
   PubMed Web of Science ®Google Scholar
• American Diabetic Association. 2014. Diagnosis and classification of diabetes mellitus. Diabetes care, 37(Supplement 1), S81–S90.
   PubMedGoogle Scholar
• Aydin, S., 2014. Three new players in energy regulation: preptin, adropin and irisin. Peptides, 56, 94–110.
   PubMed Web of Science ®Google Scholar
• Aydin, S., et al., 2014. Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I. Peptides, 58, 91–97.
   PubMed Web of Science ®Google Scholar
• Beigi, A., et al., 2015. Association between serum adropin levels and gestational diabetes mellitus; a case–control study. Gynecological endocrinology, 31(12), 939–941.
   PubMed Web of Science ®Google Scholar
• Boyle, J.P., et al., 2010. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Population health metrics, 8(1), 29.
   PubMed Web of Science ®Google Scholar
• Butler, A.A., et al., 2012. Low circulating adropin concentrations with obesity and aging correlate with risk factors for metabolic disease and increase after gastric bypass surgery in humans. The journal of clinical endocrinology and metabolism, 97(10), 3783–3791.
   PubMed Web of Science ®Google Scholar
• Celik, E., et al., 2013. Maternal and fetal adropin levels in gestational diabetes mellitus. Journal of perinatal medicine, 41(4), 375–380.
   PubMed Web of Science ®Google Scholar
• Dąbrowski, F.A., et al., 2016. First and third trimester serum concentrations of adropin and copeptin in gestational diabetes mellitus and normal pregnancy. Ginekologia polska, 87(9), 629–634.
   PubMed Web of Science ®Google Scholar
• Eckel, R.H., et al., 2011. Obesity and type 2 diabetes: what can be unified and what needs to be individualized?. The journal of clinical endocrinology and metabolism, 96(6), 1654–1663.
   PubMed Web of Science ®Google Scholar
• Ganesh Kumar, K., et al., 2012. Adropin deficiency is associated with increased adiposity and insulin resistance. Obesity, 20(7), 1394–1402.
   PubMed Web of Science ®Google Scholar
• Ghoshal, S., et al., 2018. Adropin: an endocrine link between the biological clock and cholesterol homeostasis. Molecular metabolism, 8, 51–64.
   PubMed Web of Science ®Google Scholar
• Hu, W., and Chen, L., 2016. Association of serum adropin concentrations with diabetic nephropathy. Mediators of inflammation, 2016, 1.
   Web of Science ®Google Scholar
• Kalantari, S., et al., 2019. Single and multi-locus association study of TCF7L2 gene variants with susceptibility to type 2 diabetes mellitus in an Iranian population. Gene, 696, 88–94.
   PubMed Web of Science ®Google Scholar
• Kumar, K.G., et al., 2008. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell metabolism, 8(6), 468–481.
   PubMed Web of Science ®Google Scholar
• Lovren, F., et al., 2010. Adropin is a novel regulator of endothelial function. Circulation, 122(11_suppl_1), S185–S192.
   PubMed Web of Science ®Google Scholar
• Palizban, A., et al., 2012. Association of a common variant in TCF7L2 gene with type 2 diabetes mellitus in a Persian population. Clinical and experimental medicine, 12(2), 115–119.
   PubMed Web of Science ®Google Scholar
• Pourahmadi, M., et al., 2015. Non-association between rs7903146 and rs12255372 polymorphisms in transcription factor 7-like 2 gene and type 2 diabetes mellitus in Jahrom City, Iran. Diabetes and metabolism journal, 39(6), 512–517.
   PubMed Web of Science ®Google Scholar
• Rashedi, V., et al., 2017. Prevalence of diabetes type 2 in older adults: Findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes and metabolic syndrome: clinical research and reviews, 11(Suppl 1), S347–S350.
   PubMedGoogle Scholar
• Scheen, A.J., 2003. Pathophysiology of type 2 diabetes. Acta clinica belgica, 58(6), 335–341.
   PubMed Web of Science ®Google Scholar
• Shahjouei, S., et al., 2016. Potential roles of adropin in central nervous system: review of current literature. Frontiers in molecular biosciences, 3, 25.
   PubMed Web of Science ®Google Scholar
• Topuz, M., et al., 2013. Plasma adropin levels predict endothelial dysfunction like flow-mediated dilatation in patients with type 2 diabetes mellitus. Journal of investigative medicine, 61(8), 1161–1164.
   PubMed Web of Science ®Google Scholar
• Wu, L., et al., 2014. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clinical chemistry and laboratory medicine, 52(5), 751–758.
   PubMed Web of Science ®Google Scholar
• Yan, Y., 2009. Diabetes susceptibility polymorphisms and risk of prediabetes and diabetes complications in the atherosclerosis risk in communities (ARIC) study. The University of North Carolina at Chapel Hill. Available from: https://doi.org/http://doi.org/10.17615/kpne-0v56
   Google Scholar
• Yazdanpanah, L., et al., 2016. Prevalence, awareness and risk factors of diabetes in Ahvaz (South West of Iran). Diabetes and metabolic syndrome: clinical research and reviews, 10(2 Suppl 1), S114–S118.
   PubMed Web of Science ®Google Scholar
• Yolbas, S., et al., 2016. Serum adropin level and ENHO gene expression in systemic sclerosis. Clinical rheumatology, 35(6), 1535–1540.
   PubMed Web of Science ®Google Scholar
• Yosaee, S., et al., 2016. Adropin-a novel biomarker of heart disease: a systematic review article. Iranian journal of public health, 45(12), 1568.
   PubMed Web of Science ®Google Scholar
• Yu, H.Y., et al., 2014. Serum adropin levels are decreased in patients with acute myocardial infarction. Regulatory peptides, 190–191, 46–49.
   PubMed Web of Science ®Google Scholar
• Zang, H., et al., 2018. Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index. Endocrine journal, 65(7), 685–691.
   PubMed Web of Science ®Google Scholar